Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Journal of Pharmacokinetics and Pharmacodynamics|July 8, 2011
A time scaling approach to develop an in vitro-in vivo correlation (IVIVC) model using a convolution-based techniqueCian Costello, Stefaan Rossenu, An Vermeulen, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 17, 2011
A population approach to in vitro-in vivo correlation modelling for compounds with nonlinear kineticsClare Gaynor, Adrian Dunne, Cian Costello, et al.Journal of Biopharmaceutical Statistics|November 11, 2008
Combined models for data from in vitro-in vivo correlation experimentsTom Jacobs, Stefaan Rossenu, Adrian Dunne, et al.Journal of Psychopharmacology (Oxford, England)|October 15, 2009
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophreniaJoris Berwaerts, Adriaan Cleton, Stefaan Rossenu, et al.Journal of Clinical Pharmacology|August 29, 2009
Single- and multiple-dose pharmacokinetics and dose proportionality of the psychotropic agent paliperidone extended releaseSandra Boom, Krishna Talluri, Luc Janssens, et al.Molecular Pharmaceutics|January 5, 2021
Linking In Vitro Intrinsic Dissolution Rate and Thermodynamic Solubility with Pharmacokinetic Profiles of Bedaquiline Long-Acting Aqueous Microsuspensions in RatsVy Nguyen, Jan Bevernage, Nicolas Darville, et al.Clinical Pharmacology in Drug Development|May 4, 2016
Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophreniaStefaan Rossenu, Adriaan Cleton, David Hough, et al.CNS Drugs|March 5, 2017
Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial DataMats O Magnusson, Mahesh N Samtani, Elodie L Plan, et al.Clinical Pharmacokinetics|October 16, 2016
Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with SchizophreniaMats O Magnusson, Mahesh N Samtani, Elodie L Plan, et al.Journal of Clinical Pharmacology|March 29, 2014
A single-dose, open-label, parallel, randomized, dose-proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophreniaAdriaan Cleton, Stefaan Rossenu, Herta Crauwels, et al.Pageof 21